data_10021

#Corrected using PDB structure: 1IJPA
#
#N.B. (Observed* = Observed shift + Offset correction)
#
#After reference correction, the following residues still 
#have a CA chemical shift difference (obs*-pred) greater than  5.0ppm:
#NUM  AA    CS     Observed*    Predicted
# 17   M    CA      53.47        58.53
#
#The average CS difference between predicted and observed:
#HA       CA       CB      CO       N      HN
#N/A     -0.03   -0.53   0.26      N/A     N/A   
#
#bmr10021.str.corr chemical shifts have been re-referenced with the following 
#offsets (these values have been added to the original bmr10021.str file):
#HA       CA       CB      CO       N      HN
#N/A    -0.28   -0.28  +0.26     N/A     N/A
#
#The 95% confidence intervals for the above recommended offsets are:
#    HA       CA       CB       CO       N        HN
#    N/A  +/-0.25  +/-0.30  +/-0.20      N/A      N/A  
#
#The Correlation Coefficients between predicted and observed 
#chemical shifts are:
#HA       CA       CB      CO       N      HN
#N/A     0.970   0.993   0.859     N/A     N/A   
#
#The RMSD between predicted and observed* (reference 
#corrected) chemical shifts are:
#HA       CA       CB      CO       N       HN
#N/A     0.972   1.064   0.696     N/A     N/A   
#
#*Note: CA and CB offsets differences were greater than 0.5ppm,
#       Please check for possible misassignment or deuterate effects


save_entry_information
   _Saveframe_category       entry_information

   _Entry_title             
;
Backbone and sidechain 13C and 15N Chemical Shift Assignments of H+-ATP synthase
subunit c in the solid state
;

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

      1 Kobayashi Masatoshi  . . 
      2 Matsuki   Yoh        . . 
      3 Yumen     Ikuko      . . 
      4 Fujiwara  Toshimichi . . 
      5 Akutsu    Hideo      . . 

   stop_

   _BMRB_accession_number    10021
   _BMRB_flat_file_name      bmr10021.str
   _Entry_type               new
   _Submission_date          2006-05-22
   _Accession_date           2006-05-22
   _Entry_origination        author
   _NMR_STAR_version         2.1.1
   _Experimental_method      NMR

   loop_
      _Saveframe_category_type
      _Saveframe_category_type_count

      assigned_chemical_shifts 1 

   stop_

   loop_
      _Data_type
      _Data_type_count

      "13C chemical shifts" 247 
      "15N chemical shifts"  52 

   stop_

   loop_
      _Related_BMRB_accession_number
      _Relationship

      4146 ? 

   stop_

save_


save_citation_1
   _Saveframe_category     entry_citation

   _Citation_full         
;
Signal assignment and secondary structure analysis of a uniformly [13C,
15N]-labeled membrane protein, H +-ATP synthase subunit c, by magic-angle
spinning solid-state NMR.
;
   _Citation_title        
;
13C and 15N chemical shift assignment of H+-ATP synthase subunit c in the solid
state
;
   _Citation_status        published
   _Citation_type          journal
   _PubMed_ID              17080295

   loop_
      _Author_ordinal
      _Author_family_name
      _Author_given_name
      _Author_middle_initials
      _Author_family_title

      1 Kobayashi Masatoshi  . . 
      2 Matsuki   Yoh        . . 
      3 Yumen     Ikuko      . . 
      4 Fujiwara  Toshimichi . . 
      5 Akutsu    Hideo      . . 

   stop_

   _Journal_abbreviation  "J. Biomol. NMR"
   _Journal_volume         36
   _Journal_issue          4
   _Page_first             279
   _Page_last              293
   _Year                   2006
   _Details                ?

   loop_
      _Keyword

      "Fo subunit c"        
      "MAS solid-state NMR" 

   stop_

save_


save_assembly
   _Saveframe_category      molecular_system

   _Mol_system_name        "FoF1 ATP synthase"
   _Abbreviation_common    "FoF1 ATP synthase"

   loop_
      _Mol_system_component_name
      _Mol_label

      "subunit c" $subunit_c 

   stop_

   _System_physical_state   native
   _System_oligomer_state   monomer
   _System_paramagnetic     no
   _System_thiol_state     "not present"

   loop_
      _Biological_function

      "H+ transportation" 

   stop_

save_


save_subunit_c
   _Saveframe_category     monomeric_polymer

   _Mol_type               polymer
   _Mol_polymer_class      protein
   _Name_common           "subunit c"
   _Name_variant          "subunit c"
   _Abbreviation_common   "subunit c"
   _Mol_thiol_state       "not present"
   _Residue_count          79
   _Mol_residue_sequence  
;
MENLNMDLLYMAAAVMMGLA
AIGAAIGIGILGGKFLEGAA
RQPDLIPLLRTQFFIVMGLV
DAIPMIAVGLGLYVMFAVA
;

   loop_
      _Residue_seq_code
      _Residue_label

       1 MET   2 GLU   3 ASN   4 LEU   5 ASN 
       6 MET   7 ASP   8 LEU   9 LEU  10 TYR 
      11 MET  12 ALA  13 ALA  14 ALA  15 VAL 
      16 MET  17 MET  18 GLY  19 LEU  20 ALA 
      21 ALA  22 ILE  23 GLY  24 ALA  25 ALA 
      26 ILE  27 GLY  28 ILE  29 GLY  30 ILE 
      31 LEU  32 GLY  33 GLY  34 LYS  35 PHE 
      36 LEU  37 GLU  38 GLY  39 ALA  40 ALA 
      41 ARG  42 GLN  43 PRO  44 ASP  45 LEU 
      46 ILE  47 PRO  48 LEU  49 LEU  50 ARG 
      51 THR  52 GLN  53 PHE  54 PHE  55 ILE 
      56 VAL  57 MET  58 GLY  59 LEU  60 VAL 
      61 ASP  62 ALA  63 ILE  64 PRO  65 MET 
      66 ILE  67 ALA  68 VAL  69 GLY  70 LEU 
      71 GLY  72 LEU  73 TYR  74 VAL  75 MET 
      76 PHE  77 ALA  78 VAL  79 ALA 

   stop_

save_


save_natural_source
   _Saveframe_category   natural_source


   loop_
      _Mol_label
      _Organism_name_common
      _NCBI_taxonomy_ID
      _Superkingdom
      _Kingdom
      _Genus
      _Species

      $subunit_c "E. coli" 562 Eubacteria ? Escherichia coli 

   stop_

save_


save_experimental_source
   _Saveframe_category   experimental_source


   loop_
      _Mol_label
      _Production_method
      _Host_organism_name_common
      _Genus
      _Species
      _Strain
      _Vector_name

      $subunit_c "recombinant technology" ? ? ? ? ? 

   stop_

save_


save_sample_1
   _Saveframe_category   sample

   _Sample_type          solid

   loop_
      _Mol_label
      _Concentration_value
      _Concentration_value_units
      _Isotopic_labeling

      $subunit_c 9 mg "[U-13C; U-15N]" 

   stop_

save_


save_software_1
   _Saveframe_category   software

   _Name                 FELIX2000
   _Version              ?

   loop_
      _Task

      processing 

   stop_

   _Details             "Accelrys Inc., USA"

save_


save_spectrometer_1
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Varian
   _Model                Infinity-plus
   _Field_strength       500

save_


save_spectrometer_2
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Varian
   _Model                Infinity-plus
   _Field_strength       600

save_


save_spectrometer_3
   _Saveframe_category   NMR_spectrometer

   _Manufacturer         Varian
   _Model                Infinity-plus
   _Field_strength       700

save_


save_NMR_experiment_list
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name     
;
13C-13C RFDR 
13C-13C SPC5 
15N-13CaCb 
15N-13C'CaCb 
15N-13C'-13CaCb 
13CaCb-13C'CaCb 
;

save_


save_13C-13C_RFDR
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name     "13C-13C RFDR"
   _Sample_label        $sample_1

save_


save_13C-13C_SPC5
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name     "13C-13C SPC5"
   _Sample_label        $sample_1

save_


save_15N-13CaCb
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name      15N-13CaCb
   _Sample_label        $sample_1

save_


save_15N-13C'CaCb
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name      15N-13C'CaCb
   _Sample_label        $sample_1

save_


save_15N-13C'-13CaCb
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name      15N-13C'-13CaCb
   _Sample_label        $sample_1

save_


save_13CaCb-13C'CaCb
   _Saveframe_category   NMR_applied_experiment

   _Experiment_name      13CaCb-13C'CaCb
   _Sample_label        $sample_1

save_


save_condition_1
   _Saveframe_category   sample_conditions

   _Details             
;
Precipitated from chloroform-Methanol (2:1) solvent
;

   loop_
      _Variable_type
      _Variable_value
      _Variable_value_error
      _Variable_value_units

      temperature 243 10 K 

   stop_

save_


save_reference_1
   _Saveframe_category   chemical_shift_reference

   _Details             
;
The 13C chemical shift was referenced to the methylene signal of adamantane
resonating at 31.5 ppm which gives chemical shift relative to DSS.
The 15N chemical shift reference was computed from the ratios of resonance
frequencies in the IUPAC recommendations.
;

   loop_
      _Mol_common_name
      _Atom_type
      _Atom_isotope_number
      _Atom_group
      _Chem_shift_units
      _Chem_shift_value
      _Reference_method
      _Reference_type
      _External_reference_sample_geometry
      _External_reference_location
      _External_reference_axis
      _Indirect_shift_ratio

      DSS C 13 "methyl protons" ppm 0.0 . indirect . . . 0.251449530 
      DSS N 15 "methyl protons" ppm 0.0 . indirect . . . 0.101329118 

   stop_

save_


save_assigned_chemical_shifts_1
   _Saveframe_category               assigned_chemical_shifts


   loop_
      _Experiment_label

      $13C-13C_RFDR    
      $13C-13C_SPC5    
      $15N-13CaCb      
      $15N-13C'CaCb    
      $15N-13C'-13CaCb 
      $13CaCb-13C'CaCb 

   stop_

   loop_
      _Sample_label

      $sample_1 

   stop_

   _Sample_conditions_label         $condition_1
   _Chem_shift_reference_set_label  $reference_1
   _Mol_system_component_name       "subunit c"

   loop_
      _Atom_shift_assign_ID
      _Residue_seq_code
      _Residue_label
      _Atom_name
      _Atom_type
      _Chem_shift_value
      _Chem_shift_value_error
      _Chem_shift_ambiguity_code

     4     4   LEU       CG    C     27.12      0.4     1
     5     4   LEU       CD1   C     23.62      0.4     1
     7     8   LEU       C     C    178.76      0.4     1
     8     8   LEU       CA    C     57.72      0.4     1
     9     8   LEU       CB    C     41.82      0.4     1
    10     8   LEU       CG    C     27.12      0.4     1
    11     8   LEU       CD1   C     23.62      0.4     1
    13     9   LEU       C     C    178.76      0.4     1
    14     9   LEU       CA    C     57.72      0.4     1
    15     9   LEU       CB    C     41.82      0.4     1
    16     9   LEU       CG    C     27.12      0.4     1
    17     9   LEU       CD1   C     23.62      0.4     1
    18     9   LEU       N     N    120.00      0.9     1
    19    10   TYR       CB    C     37.52      0.4     1
    20    10   TYR       CG    C    130.42      0.4     1
    21    10   TYR       CD1   C    132.32      0.4     1
    22    10   TYR       CD2   C    132.32      0.4     1
    23    10   TYR       CE1   C    117.62      0.4     1
    24    10   TYR       CE2   C    117.62      0.4     1
    25    11   MET       C     C    178.76      0.4     1
    26    11   MET       CA    C     57.52      0.4     1
    27    11   MET       CB    C     33.32      0.4     1
    28    12   ALA       C     C    179.56      0.4     1
    29    12   ALA       CA    C     54.72      0.4     1
    30    12   ALA       CB    C     17.82      0.4     1
    31    12   ALA       N     N    120.00      0.9     1
    32    13   ALA       C     C    179.56      0.4     1
    33    13   ALA       CA    C     54.72      0.4     1
    34    13   ALA       CB    C     17.82      0.4     1
    37    14   ALA       CA    C     55.12      0.4     1
    40    15   VAL       C     C    178.36      0.4     1
    41    15   VAL       CA    C     65.22      0.4     1
    43    15   VAL       CG1   C     21.62      0.4     1
    44    15   VAL       N     N    117.00      0.9     1
    46    16   MET       CA    C     59.82      0.4     1
    47    16   MET       CB    C     33.32      0.4     1
    48    17   MET       CA    C     53.22      0.4     1
    49    18   GLY       C     C    171.76      0.4     1
    50    18   GLY       CA    C     43.92      0.4     1
    51    18   GLY       N     N    112.00      0.9     1
    52    19   LEU       CA    C     53.22      0.4     1
    53    19   LEU       CB    C     46.12      0.4     1
    54    19   LEU       CG    C     27.82      0.4     1
    55    20   ALA       C     C    179.56      0.4     1
    56    20   ALA       CA    C     54.72      0.4     1
    58    20   ALA       N     N    120.00      0.9     1
    59    21   ALA       C     C    179.56      0.4     1
    60    21   ALA       CA    C     55.02      0.4     1
    61    21   ALA       CB    C     17.82      0.4     1
    62    21   ALA       N     N    120.00      0.9     1
    63    22   ILE       C     C    178.36      0.4     1
    64    22   ILE       CA    C     65.22      0.4     1
    65    22   ILE       CB    C     37.92      0.4     1
    66    22   ILE       CG1   C     29.42      0.4     1
    67    22   ILE       CG2   C     17.32      0.4     1
    68    22   ILE       CD1   C     13.82      0.4     1
    69    22   ILE       N     N    117.00      0.9     1
    70    23   GLY       C     C    175.66      0.4     1
    71    23   GLY       CA    C     47.42      0.4     1
    72    23   GLY       N     N    107.00      0.9     1
    73    24   ALA       C     C    179.56      0.4     1
    74    24   ALA       CA    C     54.72      0.4     1
    76    24   ALA       N     N    120.00      0.9     1
    77    25   ALA       C     C    179.56      0.4     1
    78    25   ALA       CA    C     55.02      0.4     1
    79    25   ALA       CB    C     17.82      0.4     1
    80    25   ALA       N     N    120.00      0.9     1
    81    26   ILE       C     C    178.36      0.4     1
    82    26   ILE       CA    C     65.22      0.4     1
    84    26   ILE       CG1   C     29.42      0.4     1
    85    26   ILE       CG2   C     17.32      0.4     1
    86    26   ILE       CD1   C     13.82      0.4     1
    87    26   ILE       N     N    117.00      0.9     1
    88    27   GLY       C     C    175.66      0.4     1
    89    27   GLY       CA    C     47.72      0.4     1
    90    27   GLY       N     N    107.00      0.9     1
    91    28   ILE       C     C    178.36      0.4     1
    92    28   ILE       CA    C     65.22      0.4     1
    93    28   ILE       CB    C     37.92      0.4     1
    94    28   ILE       CG1   C     29.42      0.4     1
    95    28   ILE       CG2   C     17.32      0.4     1
    96    28   ILE       CD1   C     13.82      0.4     1
    97    28   ILE       N     N    117.00      0.9     1
    98    29   GLY       C     C    175.66      0.4     1
    99    29   GLY       CA    C     47.72      0.4     1
   100    29   GLY       N     N    107.00      0.9     1
   101    30   ILE       C     C    178.36      0.4     1
   102    30   ILE       CA    C     65.22      0.4     1
   104    30   ILE       CG1   C     29.42      0.4     1
   105    30   ILE       CG2   C     17.32      0.4     1
   106    30   ILE       CD1   C     13.82      0.4     1
   107    30   ILE       N     N    117.00      0.9     1
   109    31   LEU       CA    C     57.52      0.4     1
   111    31   LEU       CG    C     27.12      0.4     1
   112    31   LEU       CD1   C     23.62      0.4     1
   117    33   GLY       C     C    175.66      0.4     1
   118    33   GLY       CA    C     47.02      0.4     1
   119    33   GLY       N     N    107.00      0.9     1
   120    34   LYS       CA    C     57.52      0.4     1
   121    34   LYS       CE    C     41.92      0.4     1
   122    34   LYS       NZ    N     32.80      0.9     1
   124    35   PHE       CG    C    139.62      0.4     1
   125    35   PHE       CD1   C    131.22      0.4     1
   126    35   PHE       CD2   C    131.22      0.4     1
   127    36   LEU       C     C    178.76      0.4     1
   128    36   LEU       CA    C     57.72      0.4     1
   129    36   LEU       CB    C     41.82      0.4     1
   130    36   LEU       CG    C     27.12      0.4     1
   131    36   LEU       CD1   C     23.62      0.4     1
   132    36   LEU       N     N    120.00      0.9     1
   133    37   GLU       C     C    178.36      0.4     1
   134    37   GLU       CA    C     59.02      0.4     1
   135    37   GLU       CB    C     26.52      0.4     1
   140    39   ALA       CA    C     54.72      0.4     1
   144    40   ALA       CA    C     54.72      0.4     1
   146    40   ALA       N     N    120.00      0.9     1
   147    41   ARG       CG    C     26.82      0.4     1
   148    41   ARG       CD    C     43.52      0.4     1
   149    41   ARG       CZ    C    159.32      0.4     1
   150    41   ARG       NE    N     83.70      0.9     1
   151    41   ARG       NH1   N     71.10      0.9     2
   152    41   ARG       NH2   N     74.20      0.9     2
   153    42   GLN       CA    C     54.72      0.4     1
   154    43   PRO       CA    C     62.22      0.4     1
   155    43   PRO       CD    C     49.82      0.4     1
   157    45   LEU       CA    C     53.92      0.4     1
   158    45   LEU       CB    C     46.12      0.4     1
   159    45   LEU       CG    C     27.82      0.4     1
   160    46   ILE       C     C    178.36      0.4     1
   161    46   ILE       CA    C     65.22      0.4     1
   162    46   ILE       CB    C     37.92      0.4     1
   163    46   ILE       CG1   C     29.42      0.4     1
   164    46   ILE       CG2   C     17.32      0.4     1
   165    46   ILE       CD1   C     13.82      0.4     1
   167    47   PRO       CD    C     49.02      0.4     1
   171    48   LEU       CB    C     41.82      0.4     1
   172    48   LEU       CG    C     27.12      0.4     1
   173    48   LEU       CD1   C     23.62      0.4     1
   178    49   LEU       CG    C     27.12      0.4     1
   179    49   LEU       CD1   C     23.62      0.4     1
   181    50   ARG       CG    C     26.82      0.4     1
   182    50   ARG       CD    C     43.52      0.4     1
   183    50   ARG       CZ    C    159.32      0.4     1
   184    50   ARG       NE    N     83.70      0.9     1
   185    50   ARG       NH1   N     71.10      0.9     2
   186    50   ARG       NH2   N     74.20      0.9     2
   187    51   THR       CB    C     71.02      0.4     1
   188    51   THR       CG2   C     22.02      0.4     1
   189    53   PHE       CB    C     39.02      0.4     1
   190    53   PHE       CG    C    139.62      0.4     1
   191    53   PHE       CD1   C    131.22      0.4     1
   192    53   PHE       CD2   C    131.22      0.4     1
   193    54   PHE       CB    C     39.02      0.4     1
   194    54   PHE       CG    C    139.62      0.4     1
   195    54   PHE       CD1   C    131.22      0.4     1
   196    54   PHE       CD2   C    131.22      0.4     1
   197    55   ILE       C     C    178.36      0.4     1
   198    55   ILE       CA    C     65.22      0.4     1
   200    55   ILE       CG1   C     29.42      0.4     1
   201    55   ILE       CG2   C     17.32      0.4     1
   202    55   ILE       CD1   C     13.82      0.4     1
   203    55   ILE       N     N    117.00      0.9     1
   204    56   VAL       C     C    178.36      0.4     1
   205    56   VAL       CA    C     66.32      0.4     1
   206    56   VAL       CB    C     31.32      0.4     1
   207    56   VAL       CG1   C     21.62      0.4     1
   208    56   VAL       N     N    117.00      0.9     1
   209    57   MET       C     C    178.76      0.4     1
   210    57   MET       CA    C     59.82      0.4     1
   211    57   MET       CB    C     33.32      0.4     1
   213    58   GLY       CA    C     47.42      0.4     1
   215    59   LEU       C     C    178.76      0.4     1
   216    59   LEU       CA    C     57.52      0.4     1
   217    59   LEU       CB    C     41.82      0.4     1
   218    59   LEU       CG    C     27.12      0.4     1
   219    59   LEU       CD1   C     23.62      0.4     1
   220    59   LEU       N     N    120.00      0.9     1
   221    60   VAL       C     C    178.36      0.4     1
   222    60   VAL       CA    C     66.32      0.4     1
   223    60   VAL       CB    C     31.32      0.4     1
   224    60   VAL       CG1   C     21.62      0.4     1
   225    60   VAL       N     N    117.00      0.9     1
   226    61   ASP       CA    C     57.52      0.4     1
   227    62   ALA       C     C    179.56      0.4     1
   228    62   ALA       CA    C     55.12      0.4     1
   231    63   ILE       C     C    178.76      0.4     1
   232    63   ILE       CA    C     65.62      0.4     1
   233    63   ILE       CB    C     37.92      0.4     1
   234    63   ILE       CG1   C     29.42      0.4     1
   235    63   ILE       CG2   C     17.32      0.4     1
   236    63   ILE       CD1   C     13.82      0.4     1
   237    63   ILE       N     N    117.00      0.9     1
   238    64   PRO       CA    C     64.92      0.4     1
   239    64   PRO       CD    C     49.02      0.4     1
   240    64   PRO       N     N    133.00      0.9     1
   241    65   MET       C     C    178.76      0.4     1
   242    65   MET       CA    C     58.22      0.4     1
   243    66   ILE       C     C    178.76      0.4     1
   244    66   ILE       CA    C     64.42      0.4     1
   246    66   ILE       CG1   C     29.42      0.4     1
   247    66   ILE       CG2   C     17.32      0.4     1
   248    66   ILE       CD1   C     13.82      0.4     1
   249    66   ILE       N     N    117.00      0.9     1
   250    67   ALA       C     C    179.56      0.4     1
   251    67   ALA       CA    C     55.12      0.4     1
   252    67   ALA       CB    C     17.82      0.4     1
   253    67   ALA       N     N    120.00      0.9     1
   254    68   VAL       C     C    178.36      0.4     1
   255    68   VAL       CA    C     65.22      0.4     1
   257    68   VAL       CG1   C     21.62      0.4     1
   258    68   VAL       N     N    117.00      0.9     1
   259    69   GLY       C     C    175.66      0.4     1
   260    69   GLY       CA    C     46.62      0.4     1
   261    69   GLY       N     N    107.00      0.9     1
   264    70   LEU       CB    C     41.82      0.4     1
   265    70   LEU       CG    C     27.12      0.4     1
   266    70   LEU       CD1   C     23.62      0.4     1
   268    71   GLY       C     C    175.66      0.4     1
   269    71   GLY       CA    C     47.42      0.4     1
   272    72   LEU       CA    C     57.52      0.4     1
   273    72   LEU       CB    C     41.82      0.4     1
   274    72   LEU       CG    C     27.12      0.4     1
   275    72   LEU       CD1   C     23.62      0.4     1
   277    73   TYR       CB    C     37.52      0.4     1
   278    73   TYR       CG    C    130.42      0.4     1
   279    73   TYR       CD1   C    132.32      0.4     1
   280    73   TYR       CD2   C    132.32      0.4     1
   281    73   TYR       CE1   C    117.62      0.4     1
   282    73   TYR       CE2   C    117.62      0.4     1
   283    74   VAL       C     C    178.36      0.4     1
   284    74   VAL       CA    C     66.32      0.4     1
   285    74   VAL       CB    C     31.32      0.4     1
   286    74   VAL       CG1   C     21.62      0.4     1
   287    75   MET       CA    C     59.82      0.4     1
   288    75   MET       CB    C     33.32      0.4     1
   291    76   PHE       CG    C    139.02      0.4     1
   292    76   PHE       CD1   C    131.22      0.4     1
   293    76   PHE       CD2   C    131.22      0.4     1
   299    78   VAL       CG1   C     21.22      0.4     1

   stop_

save_

